Haleos Labs Limited, formerly SMS Lifesciences India Limited, has provided an update regarding the 'Special Window' for the re-lodgement of physical share transfer requests, as per SEBI circular SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025. The company had previously communicated the opening of this window to shareholders via its website and a newspaper publication on July 23, 2025.

The special window was open from July 7, 2025, until January 6, 2026. Haleos Labs, through its Registrar and Share Transfer Agent (RTA), Aarthi Consultants Private Limited, has reported the status of requests received during the period from December 1, 2025, to January 6, 2026.

During this period, the company received zero requests for the re-lodgement of physical share transfer. Consequently, no requests were processed, approved, or rejected. The average time taken for processing requests was also NIL, as there were no applications to process. This update confirms that there was no activity related to the special window during the specified reporting period.